ADAR and prostate carcinoma: It would be worthwhile to look into whether A-to-I editing patterns on the PRUNE2/PCA3 dsRNA can be diagnostic of malignancy in human prostate cancer, and whether other lncRNAs can also serve as editing targets for ADAR1.